| Primary |
| Drug Use For Unknown Indication |
10.8% |
| Malignant Glioma |
10.3% |
| Brain Neoplasm |
8.2% |
| Lymphoma |
6.7% |
| Hodgkin's Disease Recurrent |
6.2% |
| Non-hodgkin's Lymphoma |
5.7% |
| Malignant Lymphoid Neoplasm |
5.2% |
| T-cell Chronic Lymphocytic Leukaemia |
5.2% |
| Peripheral T-cell Lymphoma Unspecified Stage Iii |
4.6% |
| Stem Cell Transplant |
4.6% |
| Chemotherapy |
4.1% |
| Glioma |
4.1% |
| Diffuse Large B-cell Lymphoma |
3.6% |
| Prophylaxis |
3.6% |
| Astrocytoma |
3.1% |
| Brain Neoplasm Malignant |
3.1% |
| Leukaemia |
3.1% |
| Central Nervous System Lymphoma |
2.6% |
| Hodgkin's Disease |
2.6% |
| Tumour Pain |
2.6% |
|
| Death |
26.9% |
| Sepsis |
9.0% |
| Subdural Haematoma |
6.4% |
| Vomiting |
6.4% |
| Neutropenic Sepsis |
5.1% |
| Anaphylactic Reaction |
3.8% |
| Leukoencephalopathy |
3.8% |
| Myelodysplastic Syndrome |
3.8% |
| Pleural Effusion |
3.8% |
| Renal Failure Acute |
3.8% |
| Thrombocytopenia |
3.8% |
| Acute Myelomonocytic Leukaemia |
2.6% |
| Brain Herniation |
2.6% |
| Herpes Zoster |
2.6% |
| Pseudomonal Sepsis |
2.6% |
| Pulmonary Fibrosis |
2.6% |
| Respiratory Failure |
2.6% |
| Sinus Tachycardia |
2.6% |
| Venoocclusive Liver Disease |
2.6% |
| Vomiting Projectile |
2.6% |
|
| Secondary |
| Non-hodgkin's Lymphoma |
14.6% |
| Mantle Cell Lymphoma |
12.0% |
| Diffuse Large B-cell Lymphoma |
9.5% |
| Hodgkin's Disease |
8.5% |
| Central Nervous System Lymphoma |
7.2% |
| Multiple Myeloma |
5.7% |
| Drug Use For Unknown Indication |
5.1% |
| Product Used For Unknown Indication |
4.4% |
| Chronic Lymphocytic Leukaemia |
3.6% |
| Stem Cell Transplant |
3.6% |
| Malignant Lymphoid Neoplasm |
3.5% |
| Plasma Cell Myeloma |
3.4% |
| B-cell Lymphoma |
3.1% |
| Prophylaxis Against Graft Versus Host Disease |
2.6% |
| Chemotherapy |
2.5% |
| Bone Marrow Conditioning Regimen |
2.5% |
| Lymphoma |
2.4% |
| Haematological Malignancy |
2.2% |
| Prophylaxis |
1.9% |
| Burkitt's Lymphoma |
1.8% |
|
| Myelodysplastic Syndrome |
10.7% |
| Pyrexia |
9.1% |
| Febrile Neutropenia |
7.1% |
| Thrombocytopenia |
7.1% |
| Mucosal Inflammation |
5.6% |
| Sepsis |
5.6% |
| Septic Shock |
5.6% |
| Stem Cell Transplant |
5.6% |
| Death |
5.1% |
| Renal Failure Acute |
5.1% |
| Acute Myeloid Leukaemia |
4.6% |
| Pneumonia |
4.6% |
| Respiratory Failure |
3.6% |
| Venoocclusive Liver Disease |
3.6% |
| Acute Myelomonocytic Leukaemia |
3.0% |
| Infection |
3.0% |
| Neutropenia |
3.0% |
| Venoocclusive Disease |
3.0% |
| Epstein-barr Virus Infection |
2.5% |
| Neurotoxicity |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.4% |
| Non-hodgkin's Lymphoma |
10.3% |
| Diffuse Large B-cell Lymphoma |
9.5% |
| Multiple Myeloma |
7.0% |
| Product Used For Unknown Indication |
6.5% |
| Mantle Cell Lymphoma |
5.0% |
| B-cell Lymphoma |
4.8% |
| Bone Marrow Conditioning Regimen |
4.4% |
| Stem Cell Transplant |
4.4% |
| Diffuse Large B-cell Lymphoma Refractory |
2.8% |
| Lymphoma |
2.6% |
| Mucosal Inflammation |
2.4% |
| Prophylaxis |
2.4% |
| Prophylaxis Against Graft Versus Host Disease |
2.1% |
| Haematopoietic Stem Cell Mobilisation |
1.7% |
| Glioblastoma Multiforme |
1.2% |
| Chronic Lymphocytic Leukaemia |
1.1% |
| Influenza |
1.0% |
| B-cell Lymphoma Recurrent |
0.8% |
| Diffuse Large B-cell Lymphoma Recurrent |
0.8% |
|
| Thrombocytopenia |
12.5% |
| Pyrexia |
11.3% |
| Wound Drainage |
10.0% |
| White Blood Cell Count Decreased |
7.5% |
| Stem Cell Transplant |
5.6% |
| Weight Decreased |
5.6% |
| Respiratory Failure |
5.0% |
| Progressive Multifocal Leukoencephalopathy |
4.4% |
| Sepsis |
4.4% |
| Acute Myeloid Leukaemia |
3.8% |
| Myelodysplastic Syndrome |
3.8% |
| Vomiting |
3.8% |
| Rash |
3.1% |
| Renal Failure Acute |
3.1% |
| Septic Shock |
3.1% |
| Urine Analysis Abnormal |
3.1% |
| Mucosal Inflammation |
2.5% |
| Subdural Haematoma |
2.5% |
| Venous Stent Insertion |
2.5% |
| Viral Infection |
2.5% |
|
| Interacting |
| Glioblastoma Multiforme |
24.0% |
| Urinary Tract Infection |
18.0% |
| Oligodendroglioma |
15.0% |
| Coordination Abnormal |
12.0% |
| Hemiparesis |
12.0% |
| Drug Use For Unknown Indication |
6.0% |
| Status Epilepticus |
5.0% |
| Metastatic Malignant Melanoma |
4.0% |
| Convulsion |
3.0% |
| Brain Oedema |
1.0% |
|
| Thrombocytopenia |
42.9% |
| Ophthalmoplegia |
21.4% |
| Paralysis |
14.3% |
| Drug Level Decreased |
7.1% |
| Sepsis |
7.1% |
| Wound Infection |
7.1% |
|
